(Q40948653)

25 September 2017

title

The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice (English)

1 reference

25 September 2017

main subject

angiogenesis inhibitor

1 reference

J L Arbiser

1

1 reference

25 September 2017

D Panigrathy

2

1 reference

25 September 2017

N Klauber

3

1 reference

25 September 2017

M Rupnick

4

1 reference

25 September 2017

E Flynn

5

1 reference

25 September 2017

T Udagawa

6

1 reference

25 September 2017

R J D'Amato

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Journal of the American Academy of Dermatology

25 September 2017

published in

1 reference

25 September 2017

volume

40

1 reference

25 September 2017

issue

6 Pt 1

1 reference

25 September 2017

page(s)

925-929

1 reference

Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Multimodal management of diffuse neonatal hemangiomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Kaposiform Hemangioendothelioma of Infancy and Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Kaposi-like infantile hemangioendothelioma. A distinctive vascular neoplasm of the retroperitoneum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970080-0

7 January 2021

10.1016/S0190-9622(99)70080-0

Identifiers

DOI

1 reference

25 September 2017

1 reference